期刊文献+

血管生成素及其Tie-2受体与2型糖尿病视网膜病变的相关性研究 被引量:7

Association of angiopoietins and soluble angiopoietin receptor Tie-2 with diabetic retinopathy in patients with type 2 diabetes
原文传递
导出
摘要 2型糖尿病增殖性视网膜病变(PDR)组血清血管生成素(Ang)2水平明显高于非增殖性视网膜病变组(NPDR)和2型糖尿病无视网膜病变组[分别为5.80(3.83—8.00)、4.42(2.56~5.55)和2.75(1.40—4.64)ng/ml,P〈0.01],NPDR组高于2型糖尿病无视网膜病变组(P〈0.01);Ang-1在NPDR组高于2型糖尿病无视网膜病变组[10.57(8.99—12.05)对9.21(7.71~11.2)ng/ml,P〈0.05];Tie-2受体在3组间差异无显著性(P〉0.05)。提示血清Ang-2水平可能与2型糖尿病视网膜病变的严重程度相关。 Angiopoietin-2 levels were5.80(3.83-8.00), 4.42(2.56-5.55), and 2.75(1.40-4.64) ng/ml in type 2 diabetic patients with proliferative retinopathy, patients with non-proliferative retinopathy, and patients without retinopathy, respectively. Statistical signifieances existed between any two groups (all P 〈 0.01 ). Angiopoietin-1 level in patients with non-proliferative retinopathy was higher than that in patients without retinopathy [ 10. 57 ( 8.99-12. 05 ) vs 9.21 (7.71-11.2 ) ng/ml, P〈0. 05 ]. No difference in receptor Tie-2 was found among the 3 groups (P〉0. 05 ). The results suggested that serum angiopoietin-2 level might be associated with the severity of retinopathy in type 2 diabetic patients.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2011年第8期639-641,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 血管生成素 受体 TIE-2 糖尿病 2型 视网膜病变 Angiopoietin Receptor Tie-2 Diabetes mellitus, type 2 Retinopathy
  • 相关文献

同被引文献98

  • 1陶丹,梅妍.糖尿病视网膜病变的病理生理学研究[J].糖尿病天地,2018,15(7):151-152. 被引量:1
  • 2李海洲,夏豪.CD163/HO-1通路激活在稳定动脉粥样硬化斑块中的作用[J].心血管病学进展,2006,27(1):57-59. 被引量:7
  • 3赵蕾,母义明,王志军,窦京涛,陆菊明,潘长玉.玻璃体血管生成素2浓度与糖尿病玻璃体出血的相关性[J].中国糖尿病杂志,2007,15(7):390-391. 被引量:1
  • 4Armulik A,Abramsson A,Betsholtz C.Endothelial-Pericyte Interactions[J].Circ Res,2005,97 (6):512-523.
  • 5Satchell SC,Mathieson PW.Angiopoietins:microvascular rnodulators with potential roles in glomerular pathophysiology[J].J Nephrol,2003,16(2):168-178.
  • 6Procoplo WN,Pelavin PI,Lee WMF,et al.Angiopoietin-1 and-2 coiled coil domains mediate distinct homo-oligomerization pattems,but fibrinogen-like domains mediate ligand activity[J].J Boil Chem,1999,274(42):30196-30201.
  • 7Suqimachi K,Tanaka S,Taquchi K,et al.Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma[J].J Clin Pathol,2003,56(11):854-860.
  • 8Loughna S,Sato TN.Angiopoietin and Tie signaling pathways in vascular development[J].Matrix Biol,2001,20(5-6):319-325.
  • 9Maisonpierre PC,Suri C,Jones PF,et al.Angiopoietin-2,a natural ancagonist for Tie2 that disrupts in vivo angiogenests[J].Science,1997,277(5292):55-60.
  • 10Valenzuela NG,Gilbert DJ,Griffitha JA,et al.Angiopoietins 3 and 4:diverging gene counterparts mice and humans[J].Proc Natl Acad Sci USA,1999,96(5):1904-1909.

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部